These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

814 related items for PubMed ID: 2936868

  • 1. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 2. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 3. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
    List SJ, Wreggett KA, Seeman P.
    J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
    [Abstract] [Full Text] [Related]

  • 4. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE, Creese I.
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR, Watanabe M, Seeman P.
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [Abstract] [Full Text] [Related]

  • 6. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH, Dvorkin B, Horowitz SG, Thal LJ.
    Brain Res; 1980 Aug 04; 194(2):403-18. PubMed ID: 6770965
    [Abstract] [Full Text] [Related]

  • 7. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P, Woodruff GN, Poat JA.
    Eur J Pharmacol; 1979 Apr 15; 55(2):137-42. PubMed ID: 456412
    [Abstract] [Full Text] [Related]

  • 8. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D, Trovero F, Blanc G, Glowinski J, Tassin JP.
    Neuroscience; 1992 Apr 15; 46(3):687-700. PubMed ID: 1532052
    [Abstract] [Full Text] [Related]

  • 9. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK, Penney JB, Young AB.
    Neuroscience; 1989 Apr 15; 30(3):767-77. PubMed ID: 2528080
    [Abstract] [Full Text] [Related]

  • 10. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH, Dvorkin B, Klein PN.
    Proc Natl Acad Sci U S A; 1982 Jul 15; 79(13):4212-6. PubMed ID: 6213964
    [Abstract] [Full Text] [Related]

  • 11. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
    List SJ, Seeman P.
    J Neurochem; 1982 Nov 15; 39(5):1363-73. PubMed ID: 7119802
    [Abstract] [Full Text] [Related]

  • 12. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 15; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 13. Affinity shifts induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors.
    Urwyler S.
    J Neurochem; 1987 Nov 15; 49(5):1415-20. PubMed ID: 2959751
    [Abstract] [Full Text] [Related]

  • 14. The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
    Andersen PH, Nielsen EB.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct 15; 59(4):315-8. PubMed ID: 2948372
    [Abstract] [Full Text] [Related]

  • 15. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb 15; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 16. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT, Dickman M.
    Invest Ophthalmol Vis Sci; 1992 Apr 15; 33(5):1620-6. PubMed ID: 1532792
    [Abstract] [Full Text] [Related]

  • 17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 15; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 18. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA.
    Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944
    [Abstract] [Full Text] [Related]

  • 19. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 20. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D, Seeman P.
    J Neurochem; 1985 Jun 07; 44(6):1925-35. PubMed ID: 3157782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.